天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 479353-63-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 479353-63-4
Chemical Structure| 479353-63-4
Structure of 479353-63-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 479353-63-4 ]

Related Doc. of [ 479353-63-4 ]

Alternatived Products of [ 479353-63-4 ]
Product Citations

Product Details of [ 479353-63-4 ]

CAS No. :479353-63-4 MDL No. :MFCD04974012
Formula : C17H24N2O4 Boiling Point : -
Linear Structure Formula :- InChI Key :JGOFKAHLQQITIG-UHFFFAOYSA-N
M.W : 320.38 Pubchem ID :2795516
Synonyms :
Chemical Name :1-Boc-4-(4-Carboxybenzyl)piperazine

Calculated chemistry of [ 479353-63-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.53
Num. rotatable bonds : 6
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 94.85
TPSA : 70.08 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.5 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.14
Log Po/w (XLOGP3) : -0.34
Log Po/w (WLOGP) : 1.52
Log Po/w (MLOGP) : 1.78
Log Po/w (SILICOS-IT) : 1.51
Consensus Log Po/w : 1.52

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.41
Solubility : 12.5 mg/ml ; 0.039 mol/l
Class : Very soluble
Log S (Ali) : -0.67
Solubility : 68.5 mg/ml ; 0.214 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.84
Solubility : 0.467 mg/ml ; 0.00146 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.41

Safety of [ 479353-63-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 479353-63-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 479353-63-4 ]

[ 479353-63-4 ] Synthesis Path-Downstream   1~14

  • 1
  • [ 914471-43-5 ]
  • [ 479353-63-4 ]
  • C27H27BrFN7O6 [ No CAS ]
YieldReaction ConditionsOperation in experiment
With pyridine; trichlorophosphate;dmap; at -15 - 100℃; for 0.08333330000000001h;Microwave; Example 51 tert-Butyl 4-{4-[({4-[(E,Z)-[(3-bromo-4-fluorophenyl)amino](hydroxyimino)methyl]-1,2,5-oxadiazol-3-yl}amino)carbonyl]benzyl}piperazine-1-carboxylate trifluoroacetate A solution of 3-(4-amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one (30 mg, 88 mumol), <strong>[479353-63-4]4-[4-(tert-butoxycarbonyl)piperazin-1-yl]methyl}benzoic acid</strong> (84 mg, 0.26 mmol), and 4-dimethylaminopyridine (6.4 mg, 53 mumol) in pyridine (0.75 mL) was treated with phosphoryl chloride (25 muL, 0.27 mmol) dropwise at -15 C. The reaction mixture was heated in a microwave at 100 C. for 5 min. The reaction mixture was concentrated to residue which was rediluted with methanol (1 mL), treated with 2.0 M sodium hydroxide in water (0.3 mL, 0.6 mmol), and stirred for 30 min. The reaction mixture was quenched with acetic acid (50 muL, 0.9 mmol), filtered, and purified by preparative LCMS to give the desired product (29 mg, 45%). LCMS for C26H30BrFN7O5 (M+H)+: m/z=618.0, 620.0.
  • 2
  • [ 479353-63-4 ]
  • [ 1414935-83-3 ]
  • [ 1414935-22-0 ]
YieldReaction ConditionsOperation in experiment
With 4-methyl-morpholine; 1,8-diazabicyclo[5.4.0]undec-7-ene; HATU; In N,N-dimethyl-formamide; at 75 - 90℃; for 4.5h; Example 2Preparation of 4-[4-(4-carbamoyl-2-pyridin-4-yl-thiazol-5-ylcarbamoyl)-benzyl]- piperazine-1 -carboxylic acid tert.-butyl ester ("A3")A mixture of 4-((4-tert.-butoxycarbonyl)piperazin-1 -yl)methyl)benzoic acid (300 mg, 0.936 mmol, 1 .0 equiv), 5-amino-2-(pyridin-4-yl)thiazole-4-carboxamide (206, 0.936, 1 .0 equiv), HATU (356 mg, 0.936 mmol, 1 .0 equiv) and N-methylmorpholine (106 muIota, 0.936 mmol, 1 .0 equiv) in dry DMF (8 ml) is heated at 75 C for 30 min. DBU (285 muIota, 1 .873 mmol, 2.0 equiv) is added and the mixture is stirred at 90 C for 4 h.The solvent is evaporated under vacuum, the residue redissolved in water (20 ml) and extracted with EtOAc (20 ml x 3 times), the organic phases are washed with brine, dried over Na2S04, filtered and evaporated. The residue is tritured with methanol, filtered and dried to afford the title compound as an off-white powder. HPLC Method: A- 0.1 % TFA in H20, B- 0.1 % TFA in ACN: Flow - 2.0ml/min.Column: X Bridge C8 (50x4.6mm.3.5 mu).
  • 3
  • [ 479353-63-4 ]
  • [ 1344034-04-3 ]
  • [ 1344034-06-5 ]
YieldReaction ConditionsOperation in experiment
48% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 18.0h; Step 4) Preparation of tert-butyl 4-(4-(2-(2-chloropyridin-4-yl)-1H-benzo[d]imidazol-4-ylcarbamoyl)benzyl)piperazine-1-carboxylate [0365]2-(2-chloropyridin-4-yl)-1H-benzo[d]imidazol-4-amine (250 mg, 1.02 mmol), 4-(4-(tert-butoxycarbonyl)piperazin-1-yl)methyl)benzoic acid (360 mg, 1.12 mmol), and HATU (583 mg, 1.53 mmol) in DMF (10 mL) was added N,N?-diisopropylethylamine (0.5 mL, 3.06 mmol). The mixture was stirred 18 h at room temperature, diluted with water (40 mL), and extracted with CH2Cl2 (10 mL×3). The combined organics layers were washed with brine, dried and concentrated. The residue was purified by silica gel column chromatography (17% to 50% Ethyl acetate in petroleum ether) to obtain tert-butyl 4-(4-(2-(2-chloropyridin-4-yl)-1H-benzo[d]imidazol-4-ylcarbamoyl)benzyl)piperazine-1-carboxylate as a yellow solid (270 mg, 48% yield). MS (ESI) calcd for C29H31ClN6O3: 546. found: 547[M+H].
  • 4
  • [ 479353-63-4 ]
  • [ 1344034-09-8 ]
  • [ 1344034-11-2 ]
YieldReaction ConditionsOperation in experiment
53% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 18.0h; Step 2) Preparation of tert-butyl 4-(4-(2-(2-(propylamino)pyridin-4-yl)-1H-benzo[d]imidazol-4-ylcarbamoyl)benzyl)piperazine-1-carboxylate [0373]2-(2-(propylamino)pyridin-4-yl)-1H-benzo[d]imidazol-4-amine (28 mg, 0.1 mmol), 4-(4-(tert-butoxycarbonyl)piperazin-1-yl)methyl)benzoic acid (20.2 mg, 0.13 mmol), and HATU (60 mg, 0.16 mmol) in DMF (5 mL) was added N,N?-diisopropylethylamine (0.05 mL, 0.31 mmol). The mixture was stirred 18 h at room temperature, diluted with water, and the resulting precipitate was collected by filtration and dried. The solid was purified by prep-TLC (6.25% MeOH in CH2Cl2) to obtain tert-butyl 4-(4-(2-(2-(propylamino)pyridin-4-yl)-1H-benzo[d]imidazol-4-ylcarbamoyl)benzyl)piperazine-1-carboxylate as a yellow solid (30 mg, 53% yield). MS (ESI) calcd for MS (ESI) calcd for C32H39N7O3: 569. found: 570 [M+H].
  • 5
  • [ 1571-08-0 ]
  • [ 479353-63-4 ]
  • 6
  • [ 57260-71-6 ]
  • [ 479353-63-4 ]
  • 7
  • tert-butyl 4-(4-(methoxycarbonyl)benzyl)piperazine-1-carboxylate [ No CAS ]
  • [ 479353-63-4 ]
YieldReaction ConditionsOperation in experiment
44.8% With lithium hydroxide monohydrate; In methanol; water; acetonitrile; at 20℃; for 1.0h; A mixture of compound 6a (7.0 g, crude, 21 mmol) and LiOH-H20 (1.4 g, 31 mmol) in methanol/acetonitrile/water (100 mL, 1 :2:2) was stirred 1 h at room temperature. The organic solvent was removed and the remaining aqueous solution was washed with ethyl acetate (100 mL) and then adjusted to pH=2-3 with 2N aqueous HC1. The resulting mixture was extracted with ethyl acetate (30 mL><2). The combined extracts were dried over anhydrous sodium sulfate and concentrated to afford compound 7a (3.0 g, 44.8%> yield) as a white solid.
3 g With lithium hydroxide monohydrate; water; In methanol; acetonitrile; at 20℃; for 1.0h; A mixture of compound 6a (7.0 g, crude, 21 mmol) and L1OH-H2O (1.4 g, 31 mmol) in methanol/acetonitrile/water (100 mL, 1 :2:2) was stirred 1 h at room temperature. The organic solvent was removed and the remaining aqueous solution was washed with ethyl acetate (100 mL) and then adjusted to pH=2-3 with 2N aqueous HC1. The resulting mixture was extracted with ethyl acetate (30 mL><2). The combined extracts were dried over anhydrous sodium sulfate and concentrated to afford compound 7a (3.0 g, 44.8% yield) as a white solid.
  • 8
  • [ 479353-63-4 ]
  • C38H40N8O3 [ No CAS ]
  • 9
  • [ 479353-63-4 ]
  • C33H32N8O [ No CAS ]
  • 10
  • [ 479353-63-4 ]
  • C20H18N6O [ No CAS ]
  • C37H40N8O4 [ No CAS ]
YieldReaction ConditionsOperation in experiment
65.2% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 0 - 20℃; for 0.25h; A mixture of compound 16 (Het=3-methylisoxazol-5-yl, 150 mg, 0.42 mmol), compound 7a (134 mg, 0.42 mmol) and HATU (159 mg, 0.42 mmol) in DMF (2 mL) was cooled to 0C and DIPEA (217 mg, 1.68 mmol) was added. The reaction mixture was allowed to warm to room temperature and stirred for 15 min. Saturated aqueous sodium bicarbonate was added and the resulting mixture was extracted with ethyl acetate. The combined extracts were dried over anhydrous sodium sulfate and concentrated. The residue was purified by flash column chromatography on silica gel (Petroleum ether/ethyl acetate = 1 : 1 to ethyl acetate) to afford compound Boc-806 (180 mg, 65.2% yield) as a solid. HCl/EtOAc (2N, 1 mL) was added to a solution of Boc-806 (97 mg, 0.147 mmol) in EtOAc (1 mL) at 0C with stirring. The reaction mixture was stirred for 1 h and the resulting precipitate was collected by filtration, washed with DCM and dried to afford compound 806 (HC1 salt, 80 mg, 100% yield) as a yellow solid.
65.2% With HATU; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0 - 20℃; for 0.25h; A mixture of compound 16 (Het=3-methylisoxazol-5-yl, 150 mg, 0.42 mmol), compound 7a (134 mg, 0.42 mmol) and HATU (159 mg, 0.42 mmol) in DMF (2 mL) was cooled to 0C and DIPEA (217 mg, 1.68 mmol) was added. The reaction mixture was allowed to warm to room temperature and stirred for 15 min. Saturated aqueous sodium bicarbonate was added and the resulting mixture was extracted with ethyl acetate. The combined extracts were dried over anhydrous sodium sulfate and concentrated. The residue was purified by flash column chromatography on silica gel (Petroleum ether/ethyl acetate = 1 : 1 to ethyl acetate) to afford compound Boc-806 (180 mg, 65.2% yield) as a solid.
  • 11
  • [ 479353-63-4 ]
  • C20H18N6O [ No CAS ]
  • C32H32N8O2*(x)ClH [ No CAS ]
  • 12
  • [ 641615-42-1 ]
  • [ 479353-63-4 ]
  • tert-butyl 4-(4-(3-(4-(5-bromopyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenylcarbamoyl)benzyl)piperazine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
80% With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 0 - 20℃; for 0.25h; A mixture of compound 5 (1.0 g, 2.81 mmol), compound 7a (0.98 g, 4.19 mmol), HATU (1.28 g, 3.37mmol) in DMF (20 mL) was cooled to 0C and DIPEA (1.95 mL, 11.24 mmol) was added. The reaction mixture was allowed to warm to room temperature and stirred for 15 min. Saturated aqueous sodium bicarbonate (20 mL) was added and the resulting mixture was extracted with ethyl acetate (50 mL><2). The combined extracts were dried over anhydrous sodium sulfate and concentrated. The residue was purified by flash column chromatography on silica gel (petroleum ether/ethyl acetate = 3 : 1 to 1 : 1) to afford compound 8a (1.29 g, 80% yield) as a yellow solid.
80% With HATU; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0 - 20℃; for 0.25h; A mixture of compound 5 (1.0 g, 2.81 mmol), compound 7a (0.98 g, 4.19 mmol), HATU (1.28 g, 3.37mmol) in DMF (20 mL) was cooled to 0C and DIPEA (1.95 mL, 11.24 mmol) was added. The reaction mixture was allowed to warm to room temperature and stirred for 15 min. Saturated aqueous sodium bicarbonate (20 mL) was added and the resulting mixture was extracted with ethyl acetate (50 mL><2). The combined extracts were dried over anhydrous sodium sulfate and concentrated. The residue was purified by flash column chromatography on silica gel (petroleum ether/ethyl acetate = 3 : 1 to 1 : 1) to afford compound 8a (1.29 g, 80% yield) as a yellow solid.
  • 13
  • [ 1642-81-5 ]
  • [ 57260-71-6 ]
  • [ 479353-63-4 ]
  • 14
  • [ 479353-63-4 ]
  • C33H36(18)FN7O3 [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 479353-63-4 ]

Aryls

Chemical Structure| 210963-04-5

[ 210963-04-5 ]

4-(((tert-Butoxycarbonyl)(methyl)amino)methyl)benzoic acid

Similarity: 0.94

Chemical Structure| 117445-22-4

[ 117445-22-4 ]

3-(((tert-Butoxycarbonyl)amino)methyl)benzoic acid

Similarity: 0.88

Chemical Structure| 33233-67-9

[ 33233-67-9 ]

4-(((tert-Butoxycarbonyl)amino)methyl)benzoic acid

Similarity: 0.88

Chemical Structure| 180863-55-2

[ 180863-55-2 ]

Methyl 3-(((tert-butoxycarbonyl)amino)methyl)benzoate

Similarity: 0.84

Chemical Structure| 162046-66-4

[ 162046-66-4 ]

4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid

Similarity: 0.84

Amides

Chemical Structure| 210963-04-5

[ 210963-04-5 ]

4-(((tert-Butoxycarbonyl)(methyl)amino)methyl)benzoic acid

Similarity: 0.94

Chemical Structure| 170097-67-3

[ 170097-67-3 ]

2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid

Similarity: 0.90

Chemical Structure| 149353-95-7

[ 149353-95-7 ]

2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid

Similarity: 0.90

Chemical Structure| 117445-22-4

[ 117445-22-4 ]

3-(((tert-Butoxycarbonyl)amino)methyl)benzoic acid

Similarity: 0.88

Chemical Structure| 33233-67-9

[ 33233-67-9 ]

4-(((tert-Butoxycarbonyl)amino)methyl)benzoic acid

Similarity: 0.88

Carboxylic Acids

Chemical Structure| 210963-04-5

[ 210963-04-5 ]

4-(((tert-Butoxycarbonyl)(methyl)amino)methyl)benzoic acid

Similarity: 0.94

Chemical Structure| 170097-67-3

[ 170097-67-3 ]

2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid

Similarity: 0.90

Chemical Structure| 149353-95-7

[ 149353-95-7 ]

2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid

Similarity: 0.90

Chemical Structure| 117445-22-4

[ 117445-22-4 ]

3-(((tert-Butoxycarbonyl)amino)methyl)benzoic acid

Similarity: 0.88

Chemical Structure| 33233-67-9

[ 33233-67-9 ]

4-(((tert-Butoxycarbonyl)amino)methyl)benzoic acid

Similarity: 0.88

Related Parent Nucleus of
[ 479353-63-4 ]

Aliphatic Heterocycles

Chemical Structure| 162046-66-4

[ 162046-66-4 ]

4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid

Similarity: 0.84

Chemical Structure| 828243-30-7

[ 828243-30-7 ]

3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

Similarity: 0.84

Chemical Structure| 149353-75-3

[ 149353-75-3 ]

4-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

Similarity: 0.84

Chemical Structure| 78551-60-7

[ 78551-60-7 ]

tert-Butyl 4-benzyl-3-oxopiperazine-1-carboxylate

Similarity: 0.83

Chemical Structure| 170838-26-3

[ 170838-26-3 ]

2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)benzoic acid

Similarity: 0.81

Piperazines

Chemical Structure| 162046-66-4

[ 162046-66-4 ]

4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid

Similarity: 0.84

Chemical Structure| 57260-70-5

[ 57260-70-5 ]

tert-Butyl 4-benzylpiperazine-1-carboxylate

Similarity: 0.84

Chemical Structure| 78551-60-7

[ 78551-60-7 ]

tert-Butyl 4-benzyl-3-oxopiperazine-1-carboxylate

Similarity: 0.83

Chemical Structure| 350684-49-0

[ 350684-49-0 ]

tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

Similarity: 0.81

Chemical Structure| 128102-16-9

[ 128102-16-9 ]

(R)-4-Benzyl 1-Boc-2-methylpiperazine-4-carboxylate

Similarity: 0.79

; ;